ObjectiveTo analyze the expressions of serum miR-378 and miR-575 in children with idiopathic epilepsy, and to explore their relations with disease sequelae. MethodsA total of 124 children with idiopathic epilepsy were regarded as epilepsy group, and 150 healthy children as health group. Children were followed up for 1 year, and children with epilepsy were assigned to complete control group (n=79) or incomplete control group (n=45) according to the control of epileptic seizure after treatment. The expressions of serum miR-378 and miR-575 were detected in all children. The predictive efficiency of serum miR-378 and miR-575 expressions for effect of seizure control in children with idiopathic epilepsy was evaluated, and the influencing factors for effect of seizure control in children with idiopathic epilepsy were also analyzed. ResultsThe expressions of serum miR-378 and miR-575 in the epilepsy group were lower than those in the health group (P<0.05). The expressions of serum miR-378 and miR-575 in the incomplete control group were lower than those in the complete control group (P<0.05). Areas under the curve (AUC) of serum miR-378 and miR-575 expressions for predicting effect of seizure control in children with idiopathic epilepsy were 0.747 and 0.852, respectively, and AUC (0.906) of the combined prediction of the two was larger than AUC of the single index (P<0.05). The results of multivariate Logistic regression analysis revealed that generalized seizure as epileptic seizure type, pre-treatment epileptic seizure frequency≥3 times per month, pre-treatment abnormal development of nervous system, serum miR-378 expression≤0.73, serum miR-575 expression≤1.83 were the risk factors for poor seizure control in children with idiopathic epilepsy (P<0.05). ConclusionSerum miR-378 and miR-575 are low-expressed in children with idiopathic epilepsy, and are related to the effect of epileptic seizure control. Both are expected to be regarded as serological biomarkers to predict effect of seizure control in children with idiopathic epilepsy.